The T-cell protein tyrosine phosphatase is expressed as two splice variants -TC45, a nuclear protein, and TC48, which is localized predominantly in the ER (endoplasmic reticulum). Yeast two-hybrid screening revealed direct interaction of TC48 with Syntaxin17, a SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) protein localized predominantly in the ER and to some extent in the ER-Golgi intermediate compartment. Syntaxin 17 did not interact with TC45. C-terminal 40 amino acids of TC48 were sufficient for interaction with syntaxin 17. Overexpressed syntaxin 17 was phosphorylated at tyrosine upon pervanadate treatment (a tyrosine phosphatase inhibitor/tyrosine kinase activator) of COS-1 cells. Mutational analysis identified Tyr156 in the cytoplasmic domain as the major site of phosphorylation. Endogenous syntaxin 17 was phosphorylated by pervanadate treatment in CHO and MIN6 cells but was not phosphorylated in a variety of other cell lines tested. c-Abl was identified as one of the kinases, which phosphorylates syntaxin 17 in MIN6 cells. Phosphorylation of endogenous and overexpressed syntaxin 17 was reduced in the presence of IGF receptor and EGF receptor kinase inhibitors. Serum depletion reduced pervanadate-induced phosphorylation of endogenous syntaxin 17. TC48 coexpression reduced phosphorylation of syntaxin 17 by pervanadate and purified TC48 directly dephosphorylated syntaxin 17. β-COP dispersal by overexpressed syntaxin 17 was reduced after pervanadate-induced phosphorylation. A phospho-mimicking mutant (Y156E) of syntaxin 17 showed reduced interaction with COPI vesicles. These results suggest that tyrosine phosphorylation of syntaxin 17 is likely to have a role in regulating syntaxin 17 dependent membrane trafficking in the early secretory pathway.
Introduction
Phosphorylation of proteins on tyrosine residues is a critical mechanism for the control of several signaling pathways in higher eukaryotes including cell proliferation and differentiation, intracellular traffic, signal transduction, etc. [1] . Protein tyrosine phosphatases (PTPs) catalyze the dephosphorylation of tyrosine phosphorylated proteins and thereby regulate their function [2] [3] [4] [5] [6] [7] . Only three PTPs are localized predominantly on internal membranes: PTP1B and TCPTP (TC48 isoform) on the endoplasmic reticulum (ER) and PTP-MEG2 on secretory vesicles [8] [9] [10] [11] . Two splice variants of TCPTP are expressed in human cells, a 48 kDa form (TC48) which is localized predominantly in the ER, and a shorter 45 kDa form (TC45) that is present in the nucleus [9] [10] [11] [12] [13] . EGF receptor, insulin receptor and Met-receptor tyrosine kinases have been identified as substrates of TC48 in the ER but they are also dephosphorylated by TC45 at the plasma membrane [14] [15] [16] . So far only one protein, C3G (RapGEF-1), has been identified as a specific substrate of TC48 which is not dephosphorylated by TC45 [17] .
After its synthesis in the ER, TC48 moves to the ERGIC (ER-Golgi intermediate compartment) and Golgi complex along the secretory pathway and its ER localization is maintained by selective retrieval [9] . It is generally believed that the retrieval of proteins from post-ER compartments is a mechanism of targeting of the protein to the ER. However, it is also possible that this cycling process may serve additional functions in post-ER compartments, for example regulation of trafficking and/or signal transduction. Some evidence for this hypothesis is provided by the finding that Golgi localized phosphorylated C3G is dephosphorylated by TC48 under physiological conditions [17] . To gain insight into the function of TC48 in the early secretory pathway and identify its substrates, we carried out a yeast two-hybrid screening and found that it interacts with a t-SNARE (target membrane SNARE) protein, syntaxin 17.
SNAREs are soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptors, which have an essential role in mediating vesicle fusion with acceptor membranes and regulating membrane dynamics in eukaryotic cells [18] [19] [20] [21] [22] [23] . SNAREs can be broadly divided as v-(vesicle membrane) or t-(target membrane) SNAREs and syntaxins are a subgroup, which are mostly present on the target membranes [24, 25] . Syntaxin 17 is ubiquitously expressed and is present predominantly in smooth ER and ERGIC membranes where it may act as a receptor protein [26] [27] [28] . Unlike other syntaxins, syntaxin 17 has two hydrophobic domains and a unique 33 amino acid lumenal tail and is highly expressed in steroidogenic cell types [27] . The function of syntaxin 17 is still not very clear, however, it was identified as a SNARE required for constitutive secretion in an siRNA screen [29] . Syntaxin 17 is essential to maintain the architecture of the ERGIC and Golgi [26] whereas syntaxin 18, another ER SNARE, is required to maintain the architecture of the ER [30] . Syntaxin 17 is also shown to be associated with certain diseases [31, 32] .
In the present study we show that TC48 interacts physically with syntaxin 17 in mammalian cells. We also show that syntaxin 17 gets phosphorylated on Tyr156 and gets dephosphorylated by TC48. One of the kinases to phosphorylate syntaxin 17 was identified to be c-Abl kinase. Phosphorylation of endogenous syntaxin 17 is seen in a cell type-specific manner and it requires serum factors. Phosphorylation of overexpressed syntaxin 17 affected β-COP distribution in the cells. Our results suggest that tyrosine phosphorylation of syntaxin 17 may be involved in regulating trafficking mediated by syntaxin 17.
Materials and methods

Cell culture and transfections
COS-1 cells and other cell lines were grown as monolayers in a humidified atmosphere of 5% CO 2 at 37°C in Dulbecco's modified Eagle's medium (DMEM) containing 10% FCS, 100 U/ml penicillin and 100 μg/ml streptomycin. Transfections were performed in COS-1 cells using the cationic lipid DHDEAB as described [33, 34] . Transfections in other cell lines were performed using Lipofectamine 2000 (Invitrogen, San Diego, CA, USA) according to the manufacturer's instructions.
Antibodies and reagents
Rabbit polyclonal anti-syntaxin 17 antibody was from Sigma (Cat No. HPA001204). Mouse monoclonal anti-ERGIC-53 was from Axxora Biochemicals. Rabbit polyclonal anti-Sec24C was a gift from Dr William E. Balch (Scripps Research Institute, San Diego, CA, USA) and has been described before [35] . Rabbit polyclonal anti-β-COP antibody was from Affinity Bioreagents and mouse monoclonal β-COP was from Sigma. Anti-GAPDH antibody was from Millipore. Protein A/G plus agarose beads, mouse monoclonal and rabbit polyclonal anti-myc antibodies, agarose conjugated anti-myc antibody, anti-GFP antibodies, mouse monoclonal anti-phosphotyrosine (pY20) antibody, anti-mouse and anti-rabbit control IgG, mouse monoclonal anti-c-Abl antibody, mouse monoclonal anti-GST antibody and anti-α-tubulin antibody were from Santa Cruz. The mouse monoclonal G11 antibody, which recognizes rat TC45, TC48, overexpressed human TC45 and TC48 proteins, has been described earlier [36] . HRP conjugated anti-mouse and antirabbit IgGs and Cy3-conjugated anti-mouse and anti-rabbit IgGs were from Amersham. Alexa-488 and Alexa-633 conjugated anti-mouse and anti-rabbit IgGs were from Molecular Probes. EGFR inhibitor (AG1478) and IGFR inhibitor (AG1024) were from Calbiochem. STI 571 was gift from Natco Pharma Ltd., and sodium orthovanadate was from Sigma. Yeast media and culture reagents were purchased from Himedia and Sigma.
Expression vectors
GFP-TC48, GFP-C40, pGBKT7-TC48, pGBKT7-TC45, pGBKT7-ΔNLS, pGBKT7-C66 and pGBKT7-C40 have been previously described [9] .
Myc-Syn17 which codes for full length rat syntaxin 17 has been described before [27] and was kindly provided by Richard H. Scheller (Stanford University, California, USA). Full-length syntaxin 17 was cloned from myc-tagged plasmids to pEGFP-C2 vector in EcoR1 and Apa1 sites to generate GFP-Syn17. Myc-Syn17 was mutated to myc-Y156F and myc-Y156E mutant by site directed mutagenesis following the protocol described in QuickChange Site directed mutagenesis kit (Stratagene). During yeast two-hybrid screening process of human placental cDNA library, a smaller construct of syntaxin 17 in pACT-II (ΔNSyn17) was obtained which codes for 121-302 aa. This cDNA was further cloned in a pcDNA3.1 vector with HA tag at the 5'-end of cDNA to generate the HA-ΔNSyn17 construct. Deletion construct of human syntaxin 17, TMCT was prepared by amplifying the region from 229 to 302 aa by PCR and cloning in the BamH1 and Xho1 sites of pACT-II. The deletion constructs of syntaxin 17, SDTM and NSDM were prepared by inserting a stop codon at 274 aa and 229 aa positions, respectively, using site directed mutagenesis in pACT-II. GST-TC48 was constructed by excising full length TC48 from pMOS clone (described in [9] ) with EcoR1 and Sal1 and cloned into pGEX-5X-2 vector. Human c-Abl expression vector c-Abl-pSGT was from Dr Richard Van Etten and has been referred earlier [37] .
Yeast two-hybrid screening
Yeast two-hybrid screening was carried out using the yeast strain PJ69-4A [38] and the full-length TC48 protein was used as bait protein. The TC48 (pGBKT-7)-expressing PJ69-4A strain was transformed with human placental cDNA library in pACT-II vecor (Clontech). The procedure followed has been described previously [9] . The interactions were confirmed by retransformation of positive clones with TC48 or control plasmids by plating on yeast dropout medium lacking Trp, Leu and Ade. The interaction was also tested by the activation of β-galactosidase reporter gene by plating them on plates containing Trp and Leu dropout medium (adjusted to pH 7.0) and β-galactosidase substrate.
Indirect immunofluorescence and confocal microscopy
For immunofluorescence COS-1 cells were grown on coverslips, transfected with required plasmids and fixed after 24 h. The cells were then immunostained with required antibodies. Indirect immunostaining of cells was carried out as described earlier [9, 39] . Colocalization was determined by observing the staining patterns, with the LSM 510 Meta NLO Confocal Microscope from Carl Zeiss. Serial optical sections in the Z-axis of the cell were collected at 0.33 μm intervals with 63× oil immersion objective lens (NA 1.4). Then, two middle optical sections were projected and colocalization was observed by using LSM 510 (version 3.2) software. Quantification analysis of co-localization was done by calculating Pearson's correlation coefficients using LSM 510 software.
Co-immunoprecipitation and western blotting
For co-immunoprecipitation, cells in 60-mm dishes were transfected with required plasmids and after 36 h, cells were washed with ice-cold PBS and then lysed at 4°C for 20 min in lysis buffer containing 25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1.0% Triton X-100, 1 mM PMSF, 0.1% BSA, 5 mM EDTA and protease inhibitor cocktail (Roche Biochemicals). Lysates were centrifuged at 10,000 rpm for 12 min at 4°C and the supernatant was used for immunoprecipitation using 2 μg of antibody or 2 μg of normal IgG as control antibody. Supernatants were either incubated overnight with antibodies and then 20 μl protein A/G plus agarose beads were added for another hour at 4°C or the supernatants were incubated with antibody conjugated agarose beads for 4 h at 4°C. Then the beads containing immune complexes were given three washes in wash buffer (20 mM Hepes pH 7.4, 0.1% Triton X-100, 150 mM NaCl, 10% glycerol, 1 mM PMSF, and protease inhibitors) and boiled after adding 10 μl of 3× SDS-PAGE sample buffer. In case immunoprecipitations were done for phosphorylated proteins, 2 mM sodium orthovanadate and 10 mM sodium fluoride were added in lysis buffer and wash buffer. The samples were resolved in SDS-PAGE and transferred to nitrocellulose membrane for western blot analysis. Western blotting was performed using standard protocols as described earlier [9] .
In vitro dephosphorylation assay
GST and GST-TC48 were expressed in E. coli strain BL21 and were purified using glutathione-Sepharose beads and eluted with neutralized reduced glutathione. Enzymatic activity of GST-TC48 was determined by using artificial tyrosine phosphatase substrate, paranitrophenyl phosphate (pNPP). GST-TC48 or GST were incubated with 5 mM pNPP in 50 mM Tris-HCl (pH 7.1) reaction buffer at 30°C for 5-10 min in a volume of 100 μl and then the reaction was stopped by adding 1 ml of 2 M sodium carbonate and absorbance was measured at 430 nm [40] . COS-1 cells were transfected with myc-Syn17 and after 36 h of expression, tyrosine phosphorylation of syntaxin 17 was stimulated by treating the cells with 0.1 mM pervanadate for 20 min. Then syntaxin 17 was immunoprecipitated with agarose conjugated anti-myc antibody. The immune complexes were washed twice with wash buffer and once with dephosphorylation assay buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5 mM DTT, 0.02% Triton-X 100 and 0.2 mM EDTA] and incubated with either GST-TC48 or GST proteins in dephosphorylation buffer at 30°C for 15 min. The reaction was stopped by adding 3× SDS-PAGE sample buffer.
Pervanadate treatment
Cells were subjected to pervanadate treatment by addition of freshly prepared 0.1 mM solution of pervanadate for required time prior to harvesting as described earlier [34] . Pervanadate stock solution (50 mM) was prepared by mixing equal volumes of 100 mM solution of H 2 O 2 and 100 mM solution of sodium orthovanadate.
Statistical analysis
Graphs were represented as average ± SD values. Differences between averages were tested using Student's t test. P values obtained less than 0.05 were considered significant. In pair wise comparisons p values were denoted as *, **, or *** in the graphs based on whether they were less than 0.05, 0.01 or 0.001, respectively.
Results
Identification of Syntaxin 17 as TC48-interacting protein
To understand the functional significance of presence of TC48 in early secretory pathway and identify its interacting partners we carried out yeast two-hybrid screening using full length TC48 as bait. One of the positives identified as TC48-interacting protein was syntaxin17. The cDNA clone obtained codes for aa 121-302 of human syntaxin 17, which encompasses N-terminal cytoplasmic domain partially, the conserved SNARE domain, the two hydrophobic domains and the unique C-terminal lumenal domain. The interaction of syntaxin 17 with TC48 was specific as it did not interact with the other splice variant TC45 or with the N-terminal catalytic region, which is common in TC48 and TC45, or with the protein expressed by control plasmid pGBKT7 (Fig. 1A) . In TC48, the last 6 amino acids of TC45 are replaced by 34 mostly hydrophobic amino acids [11, 12] . This suggests that it is the C-terminal hydrophobic region of TC48 that interacted with syntaxin 17. We further determined that the C-terminal 40 aa were actually sufficient for interaction with syntaxin 17 by using two deletion constructs of TC48, C-66 (C-terminal 66 aa) and C-40 (C-terminal 40 aa) ( Fig. 1A and B ). Similarly, different deletion constructs of syntaxin 17 were made to determine the domains required for interaction with TC48. The truncated construct of syntaxin 17, which lacked the C-terminal tail (121-273 aa -SDTM), showed somewhat weaker interaction with TC48 as it showed delayed growth on Ade deficient plates ( Fig. 1C and D) . The construct of syntaxin 17, which lacked the C-terminal tail as well as both the hydrophobic domains (121-228 aa -NSDM), did not interact with TC48. The TMCT construct (227-302 aa), which had only the two hydrophobic domains and the C-terminal tail, also did not show interaction with TC48 ( Fig. 1C and D) . This suggests that the hydrophobic domains of syntaxin 17 were required but not sufficient for interaction with TC48.
We next examined the interaction of TC48 and syntaxin 17 in mammalian cells. The plasmids expressing GFP tagged full length human TC48 and myc tagged full length rat syntaxin 17 (myc-Syn17) were coexpressed in COS-1 cells; after 36 h cell lysates were prepared and immunoprecipitation was carried out using either myc antibody or control antibody. Western blot analysis showed the presence of TC48 in the immunoprecipitate with myc antibody but not in the immunoprecipitate with control antibody (Fig. 1E ). This result showed that overexpressed TC48 and syntaxin 17 interacted with each other. We also examined the interaction of TC48 with endogenous syntaxin 17. First we analyzed the expression of endogenous syntaxin 17 in some commonly used mammalian cell lines using a commercial antibody from Sigma. Endogenous syntaxin 17 was detectable as a 38 kDa major band with this antibody in COS-1, HeLa, HepG2, A549 and HEK293 cells whereas over-expressed syntaxin 17 showed slower mobility due to the addition of myc tag (Fig. 1F ). GFP-TC48 was overexpressed in COS-1 cells for 36 h and immunoprecipitation was carried out with GFP antibody or control antibody. Endogenous syntaxin 17 was detected in the immunoprecipitate with GFP antibody but not with control antibody (Fig. 1G ). To examine the interaction of endogenous syntaxin 17 with endogenous TC48 we used CHO cell line as the antibodies against both the proteins worked in this cell line. CHO cell lysates were subjected to immunoprecipitation using G11 antibody, which recognizes both isoforms of TCPTP [36] , followed by western blotting. Endogenous syntaxin 17 was detected in the immunoprecipitate with G11 antibody but not with control antibody ( Fig. 1H ). This suggested that endogenous syntaxin 17 interacted with endogenous TC48; this interaction was probably not with TC45 isoform as we showed that syntaxin 17 interacted specifically with TC48 isoform and not with TC45 in yeast two-hybrid assay.
TC48 colocalizes with syntaxin 17
Since TC48 interacts with syntaxin 17 we examined the possibility of their colocalization in mammalian cells. GFP-TC48 when coexpressed with myc-Syn17 in COS-1 cells showed colocalization in some perinuclear areas of the cell ( Fig. 2A) . GFP-TC48 also showed colocalization with endogenous syntaxin 17 in COS-1 cells (Fig. 2B ). Since syntaxin 17 is present in the ER as well as ERGIC, we dual-stained GFP-TC48 expressing cells with antibodies that recognize ERGIC-53, a marker for ERGIC, along with endogenous syntaxin 17. TC48 colocalized with syntaxin 17 in ERGIC and outside ERGIC (Fig. 2B) . These results suggest TC48 and syntaxin 17 colocalize in the ER as well as ERGIC.
Syntaxin17 gets phosphorylated on tyrosine
Interaction of syntaxin 17 with TC48 tyrosine phosphatase led us to investigate the possibility of its regulation by tyrosine phosphorylation. Myc-Syn17 was overexpressed in COS-1 cells and after 30 h the cells were either treated with 0.1 mM pervanadate for 20 min or left untreated. Pervanadate is an inhibitor of protein tyrosine phosphatases and an activator of some protein tyrosine kinases. A. The yeast strain PJ69-4A was transformed with the pairs of indicated expression plasmids expressing hybrid proteins fused to the GAL4-DNA-binding domain (TC48 or TC45 or Δ-NLS or control vector pGBKT7, C) and to the GAL4-activation-domain (syntaxin 17 cloned in pACTII) (upper panels). The yeast strain was cotransformed with syntaxin 17 and TC48 or its deletion constructs, C-66 and C-40 (lower panels). Transformants were plated on medium without (Ade − ) or with (Ade + ) adenine. Growth in the absence of adenine indicates the interaction between hybrid proteins. Each patch represents an independent transformant. Transformants were also grown on plates supplemented with β-galactosidase substrate X-gal (X-gal+) as lacZ is an additional reporter gene. Blue color development of colonies indicates interaction between the two proteins. B. Schematic representation of TC48, TC45 and their deletion constructs. C. Yeast strain PJ69-4A was co-transformed with TC48 (cloned in pGBKT-7) and various mutants of syntaxin 17. Transformants were grown on plates with (Ade + ) or without adenine (Ade − ). D. Schematic representation of syntaxin 17 and its deletion constructs. E. Interaction of overexpressed Syntaxin 17 and TC48. COS-1 cells cotransfected with GFP-TC48 and myc-Syn17 plasmids were subjected to immunoprecipitation using myc antibody or control antibody. Immunoprecipitates were analyzed by western blotting. F. Western blot shows expression of endogenous syntaxin 17 in mammalian cell lines. CDK2 is a loading control. G. Interaction of endogenous syntaxin 17 with GFP-TC48. COS-1 cells were transfected with GFP-TC48 and immunoprecipitation was carried out using GFP antibody or control antibody. The immunoprecipitates were analyzed by western blotting. H. Interaction of endogenous syntaxin 17 with endogenous TC48. CHO cell lysates were subjected to immunoprecipitation using G11 antibody or control antibody and resolved in SDS-PAGE and analyzed by western antibody using syntaxin 17 and G11 antibodies.
Immunoprecipitation was carried out using anti-myc antibody and western blot analysis using an anti-phospho-tyrosine monoclonal antibody showed a band at 45 kDa in the immunoprecipitate from pervanadate treated cells but not from the untreated cells (Fig. 3A) . When this blot was reprobed with anti-myc antibody, two bands were visible in the pervanadate treated immunoprecipitate compared to single band in the untreated sample. The slower migrating band (myc blot) corresponded to the 45 kDa band detected in the phosphotyrosine blot. These results suggest that syntaxin 17 gets phosphorylated on tyrosine and phosphorylated syntaxin 17 shows slower mobility than the non-phosphorylated form in SDS-PAGE.
Syntaxin17 has 3 tyrosines and bioinformatic analysis using Scansite
Motif Scan suggested that Tyr-156 of rat syntaxin 17 (Tyr-157 in human protein) was most likely to be the site of phosphorylation. We created Y156F mutant of full-length rat syntaxin 17 by site directed mutagenesis. COS-1 cells were transfected with Y156F-Syn17 mutant and treated with pervanadate. Y156F-Syn17 did not show any mobility shift in pervanadate treated cells (Fig. 3B) suggesting, therefore, that Tyr-156 is the major site of phosphorylation in syntaxin 17. Moreover Y156F-Syn17 showed slightly faster mobility than wild type syntaxin 17. Tyrosine at 156 position was found to be conserved in various mammalian species (Fig. 3C) . A. GFP-TC48 and myc-Syn17 were cotransfected in COS-1 cells. Cells were fixed after 24 h and immunostained with myc antibody followed by Cy3-conjugated secondary antibody (red) and observed by confocal microscopy. Yellow color generated in the merged image shows colocalization of TC48 with syntaxin 17. B. GFP-TC48 was transfected in COS-1 cells and after 24 h cells were fixed and immunostained with syntaxin 17 antibody followed by Cy3-conjugated secondary antibody (red) and ERGIC-53 antibody followed by Alexa-633-conjugated secondary antibody (blue). Colocalization was analyzed by confocal microscopy. Scale bar: 10 μm.
We tried to identify the tyrosine kinases which are likely to phosphorylate syntaxin 17. Pervanadate is known to activate several tyrosine kinases including c-Abl. Bioinformatic analysis predicted that c-Abl was likely to phosphorylate Tyr-156 of rat syntaxin 17. Therefore c-Abl was transfected with myc-Syn17 and the cells were treated with H 2 O 2 (an activator of c-Abl) or left untreated. Western blot analysis showed that c-Abl could phosphorylate syntaxin 17 as seen by the appearance of the shifted band (Fig. 4A) . This phosphorylation increased when c-Abl was activated by treatment of cells with H 2 O 2 (Fig. 4A ). The Y156F mutant of syntaxin 17 was not phosphorylated by c-Abl (Fig. 4A ). c-Abl interacted with syntaxin 17 as determined by co-immunoprecipitation ( Fig. 4B) , which suggested that c-Abl directly phosphorylated syntaxin 17. Phosphorylation induced by c-Abl was reduced when cells are treated with STI571 (c-Abl kinase inhibitor) prior to the treatment of cells with H 2 O 2 (Fig. 4C) . Treatment of the cells with EGFR kinase inhibitor (AG1478) or IGFR kinase inhibitors (AG1024) reduced phosphorylation of syntaxin 17 induced by pervanadate treatment of the cells (Fig. 4D) indicating that there are other tyrosine kinases involved in tyrosine phosphorylation of syntaxin 17. These results suggest that c-Abl is one of the tyrosine kinases, which can phosphorylate syntaxin 17.
Phosphorylation of endogenous syntaxin 17 and its dependence on serum factors
To analyze the phosphorylation of endogenous syntaxin 17, various cell lines were treated with pervanadate. A band of slower mobility corresponding to phosphorylated syntaxin 17 was seen after pervanadate treatment in CHO cells (Fig. 5A) but not in many other cell lines tested ( Fig. 5C ; data not shown for Huh7 and THP1 cells). Increase in phosphorylation of syntaxin 17 in CHO cells was seen when time of pervanadate treatment was increased (Fig. 5A) . Phosphorylation of endogenous syntaxin 17 in CHO cells was reduced when cells were treated with IGFR and EGFR kinase inhibitors prior to pervanadate treatment (Fig. 5B) as it was seen with overexpressed syntaxin 17 in COS-1 cells, though no reduction in phosphorylation was seen when cells were pre-treated with c-Abl kinase inhibitor (STI571). Since growth factors are present in serum, we examined the effect of serum starvation on pervanadate-induced phosphorylation of syntaxin 17. Phosphorylation of endogenous syntaxin 17 was reduced when CHO cells were serum starved for 4 h prior to pervanadate treatment (Fig. 5D ). In addition to CHO cells, MIN6 cell line (a mouse pancreatic beta cell line) showed phosphorylation of endogenous syntaxin 17 (Fig. 6A ). But, in MIN6 cells, pre-treatment with STI571 reduced the phosphorylation of syntaxin 17 (Fig. 6B) . However, the extent of reduction was less when compared to pre-treatment with IGFR inhibitor, and significant reduction of phosphorylation was not seen when pre-treated with EGFR inhibitor (Fig. 6B) . Overexpressed c-Abl kinase phosphorylated endogenous syntaxin 17 in MIN6 cells after activation with H 2 O 2 (Fig. 6C ). Only slight reduction in phosphorylation of syntaxin 17 was seen upon serum starvation in MIN6 cells (Fig. 6D) . These results suggested that phosphorylation of syntaxin 17 occurs in a cell type-specific manner, and is mediated by growth factor receptor kinases and c-Abl in different cell types.
Syntaxin 17 is a substrate of TC48
Since syntaxin 17 directly interacts with TC48, it may be a substrate of TC48. To test this hypothesis, in vitro dephosphorylation assay was carried out using purified recombinant GST-TC48 (Fig. 7A) , which exhibited catalytic activity against artificial substrate, para-nitrophenyl phosphate (data not shown). COS-1 cells overexpressing myc-Syn17 were given pervanadate treatment for 20 min and immunoprecipitation was carried out using agarose-conjugated myc antibody. Purified GST-TC48 fusion protein or control GST protein was added to the immune complexes and the dephosphorylation assay was carried out at 30°C for 15 min. The reaction was stopped by adding SDS sample buffer and the samples were analyzed by western blotting using phosphotyrosine antibody. Incubation of phosphorylated syntaxin 17 with GST-TC48 resulted in complete dephosphorylation of phosphorylated syntaxin 17, whereas incubation with GST did not (Fig. 7B ). This result shows that syntaxin 17 is a direct substrate of TC48. If syntaxin 17 is a substrate of TC48, then coexpression of TC48 is expected to decrease phosphorylation of syntaxin 17 in the cells. To test this hypothesis myc-Syn17 was expressed with and without TC48 and the cells were treated with pervanadate. Western blot analysis showed that the level of slower migrating band of syntaxin 17 decreased in TC48 expressing cells (Fig. 7C ).
Effect of syntaxin 17 phosphorylation on COPI vesicles
Recently, we have shown that overexpression of syntaxin 17 affects the staining pattern of β-COP (COPI vesicle marker) from tight juxtanuclear staining to diffuse cytoplasmic staining in majority of the cells [26] . We determined the effect of tyrosine phosphorylation of syntaxin 17 on COPI vesicle distribution by treating the cells with pervanadate. Analysis of pervanadate treated myc-Syn17 expressing cells showed that staining of β-COP (a marker for COPI vesicles) was undisturbed in approximately 42% of the cells whereas in the control set in 23% of the expressing cells, β-COP staining was not disturbed (Fig. 8A and C) . Pervanadate treatment of cells did not affect subcellular localization of Y156F-Syn17 mutant and beta-COP distribution in Y156F-Syn17 expressing cells ( Fig. 8B and C) . These results suggest that tyrosine phosphorylated syntaxin 17 is unable to redistribute or disrupt COPI vesicles. To further understand the role of phosphorylation of Tyr-156 of syntaxin 17 on distribution of COPI vesicles we generated a phospho-mimicking mutant of syntaxin 17, Y156E-Syn17. We observed that 29% of cells expressing Y156E-Syn17 mutant showed intact β-COP staining as compared to 21% of wild-type syntaxin 17 expressing cells (Fig. 8D ).
A phospho-mimicking mutant of syntaxin 17 (Y156E) shows altered interaction with β-COP
Previously we have shown that overexpressed syntaxin 17 interacts with β-COP [26] , a component of COP1 vesicles. The interaction of Y156E-Syn17 mutant with β-COP was examined in transfected cells by immunoprecipitation. Compared to wild-type syntaxin 17, the Y156E-Syn17 mutant showed reduced interaction with β-COP whereas no difference in interaction with Sec24C (ER-exit site and COPII vesicle component) was observed (Fig. 8E) . This result provides support to our suggestion that the phosphorylation of syntaxin 17 affects its ability to interact with COPI vesicles.
Discussion
The TC48 tyrosine phosphatase is predominantly localized to the ER. It has been shown previously that TC48 cycles between the ER and post-ER compartments [9] . The functions attributed to TC48 in the ER are dephosphorylation of EGFR, IR and Met-receptor tyrosine kinases, which are also the substrates of its other splice variant, TC45 [14] [15] [16] . Phosphorylated C3G localized in the Golgi is dephosphorylated by TC48 but not by TC45 [17] . However, the function of TC48 in regulation of intracellular vesicle trafficking or vesicular trafficking in the early secretory pathway is yet to be explored. Here, we have identified syntaxin 17, a SNARE protein present mainly in the ER, as a TC48-interacting protein. This interaction is mediated by C-terminal non-catalytic sequence of TC48, which is also involved in its trafficking through post-ER compartments and retrieval/targeting to the ER [9] . Our results also show that TC48 is able to dephosphorylate syntaxin 17 phosphorylated at tyrosine. Since TC48 shows colocalization with syntaxin 17 in and around ERGIC, this interaction may serve the purpose of anchoring or targeting TC48 to specialized domains of ER and/or ERGIC.
Interaction of syntaxin 17 with TC48 tyrosine phosphatase led us to investigate the possibility of syntaxin 17 regulation by tyrosine phosphorylation. In this study, we present evidence for tyrosine phosphorylation of syntaxin 17. Overexpressed syntaxin 17 gets phosphorylated at tyrosine by endogenous kinases in pervanadate treated cells and by overexpression of c-Abl tyrosine kinase. We have identified that Tyr156 of rat syntaxin 17 as the predominant site of phosphorylation by mutagenesis. Our results show that recombinant GST-TC48 dephosphorylated syntaxin 17 in vitro and coexpression of TC48 in mammalian cells reduced pervanadate-induced phosphorylation of syntaxin 17. This suggested that syntaxin 17 not only interacts with TC48 but also acts as a substrate for TC48. Endogenous syntaxin 17 showed phosphorylation specifically in CHO and MIN6 cells and it did not show phosphorylation in many other cell lines. This suggests that tyrosine phosphorylation of endogenous syntaxin 17 is tightly regulated and is probably cell type specific. IGFR kinase inhibitor reduced phosphorylation of endogenous syntaxin 17 in both the cell lines (CHO and MIN6), but Abl kinase inhibitor reduced phosphorylation only in MIN6 cells, and EGFR kinase inhibitor reduced phosphorylation in CHO cells. This suggests that phosphorylation of syntaxin 17 is mediated by different kinases in different cell types.
The phosphorylation of syntaxin 17 may affect its interaction with components or regulators of membrane vesicle trafficking. This hypothesis is supported by the finding that pervanadate-induced phosphorylation of syntaxin 17 at Tyr156 resulted in reduced dispersion of β-COP staining (COPI vesicles marker). In addition, a phospho-mimicking mutant of syntaxin 17 shows reduced interaction with COPI vesicles. These results are consistent with the suggestion that tyrosine phosphorylation of syntaxin 17 may be involved in regulating trafficking in the early secretory pathway. Since TC48 could dephosphorylate syntaxin 17, it may be involved in regulating the tyrosine phosphorylationdependent functions of syntaxin 17.
SNAREs are known to undergo various posttranslational modifications including sumoylation, ubiquitination, palmitoylation, prenylation and others [41] [42] [43] [44] [45] [46] [47] [48] [49] . The posttranslational modifications of proteins by serine/threonine phosphorylations have been shown to have a profound effect on intracellular trafficking [50] [51] [52] . There are only few reports which show involvement of tyrosine phosphorylation in regulation of intracellular vesicle transport. Tyrosine phosphorylation of Munc18C, the negative regulator of syntaxin 4, results in disruption of Munc18C-Syntaxin 4 complex which stimulates vesicle exocytosis in 3T3L1 adipocytes [53, 54] . Tyrosine phosphorylation of NSF prevents its binding to α-SNAP [55] . NSF and α-SNAP binding is necessary for dissociation of cis-SNARE complexes to promote fusion events. Dephosphorylation of NSF by PTP-MEG2 (secretory vesicle tyrosine phosphatase) activated NSF and promoted the fusion of syntaxin 6-containing secretory vesicles [55] . PTP1B is also shown to dephosphorylate and positively modulate NSF in human sperms which results in elicitation of cis-SNARE complex disassembly during sperm exocytosis [56] . In vitro studies have shown that tyrosine phosphorylation state of NSF-related protein, p97, plays a regulatory role in transitional ER assembly. JAK2 (intracellular non-receptor tyrosine kinase) and PTPH1 (non-receptor PTPase) have been identified as the relevant regulators of p97 [57] . Thus very little is known about the involvement of tyrosine phosphorylation in the early secretory pathway. Our results showing tyrosine phosphorylation of syntaxin 17 provide a basis for further exploring the role of this post-translational modification and the tyrosine kinases and PTPases in controlling membrane trafficking between ER and Golgi.
Conclusions
In conclusion, our results show that syntaxin 17 is phosphorylated at tyrosine 156, a site close to the SNARE domain. Phosphorylation of endogenous syntaxin 17 is dependent on cell type and is mediated by c-Abl and growth factor receptor kinases. Syntaxin 17 directly interacts with the tyrosine phosphatase TC48 and it is a substrate of TC48. Our results raise the possibility of a role for tyrosine phosphorylation in regulating vesicle trafficking in the early secretory pathway.
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